Delve Health
Share
Decentralized Clinical Trial Solution, bringing clinical trials to patient homes
06/09/2026
A dead battery can sink a primary endpoint.
Not the protocol. Not the platform. A charger that broke in week 3, a device that stopped syncing on day 4, a patient who didn't think it was worth a phone call.
The science is hard. The software is solved. The part that quietly breaks trials is the logistics — getting the right device to the right patient, keeping it working, and catching the failure before it becomes a hole in your data.
That's what concierge support and device logistics are for: real people and real operational follow-up that keep patients equipped and engaged between visits. Insurance for your endpoints, not another dashboard.
More data doesn't help if the device was dead when it mattered.
05/21/2026
Here's something that quietly derails wearable-enabled clinical trials: enrollment isn't adoption.
A device on a patient's wrist isn't the same as a device worn correctly, charged, and synced every day. And when patients drift, it doesn't show up in the enrollment numbers — it shows up later, in the endpoint data, as gaps you can't fix after the fact.
The technology is the easy part. Keeping patients using it correctly, week after week, is the real work — and it takes setup support, monitoring for non-wear, and follow-up the moment the data stops.
How does your team keep wearable data flowing once the novelty wears off?
More on how we approach this: https://www.delvehealth.com/wearable-compliance-clinical-trials.html
Subject matter expertise is key when using AI tools like ChatGPT. If you understand the topic, you can identify errors. Power requires responsibility.
See full video here https://youtu.be/AFtsMb1_4VA
It's not about the fancy tech; it's about empowering people. Think GPS for drivers—it guides, but doesn't replace skill. We can train good clinicians for new protocols, but not with scattered resources. Let's focus on enabling participation.
Dropout rates and late trial starts cost the industry billions. The human element is key to engagement and retention, yet we often overlook what makes people comfortable. Standardized measurement in behavioral and survey science can turn subjective feedback into reliable data, proving ROI and serving patients better.
04/22/2026
omething worth sharing if you work in clinical research:
The industry has made serious progress on wearable technology in clinical trials. Devices are more capable than ever. Regulatory acceptance is growing — the FDA expanded its real-world evidence framework just last December.
But there's a gap that doesn't get talked about enough.
Collecting the data and using the data are two very different problems.
A wearable can generate thousands of data points per patient per day. If the analytics aren't protocol-aligned, if patients aren't supported through the full study duration, if sites don't have clean workflows around the device — that data doesn't do what you needed it to do.
The teams getting this right aren't just deploying better devices. They're building better ex*****on infrastructure around them.
That's the real differentiator in 2026.
New full episode is live on Spotify.
Clinical trials have more technology, more tools, and more data than ever before.
So why are patient retention, trial compliance, and patient experience still such persistent problems?
In this episode, I sat down with Farah Ahmad, Co-Founder and CEO of PatientX and EVP of Business Development at Eversana, for a candid conversation about what the industry still gets wrong when it comes to the patient journey.
We talked about:
• patient retention in clinical trials
• patient engagement and patient voice
• trial compliance and operational gaps
• decentralized clinical trials and digital health
• clinical trial innovation and better trial design
• how sponsors, sites, and partners can work better together
One of the biggest takeaways for me: we keep trying to solve deeply human problems with disconnected systems, fragmented processes, and too little ownership around the actual participant experience.
If we want better data, better compliance, and better outcomes, we have to build trials that work better for the people inside them.
This conversation is for anyone working in clinical research, clinical operations, pharma, biotech, digital health, or patient-focused innovation.
Listen to the full episode on Spotify and let me know what you think the industry still misses most when it comes to retention.
04/06/2026
Big news! 🏆 Delve Health has officially been named one of the Fastest-Growing Companies in the Midwest by ! 🚀
From 2022 to 2025, our team has been on a mission to transform clinical trials and make healthcare more accessible through innovation. Being recognized on the list is a huge milestone for us, and it’s all thanks to our incredible team, partners, and clients.
We’re not just growing; we’re evolving the future of health-tech. Thank you for being part of our journey! 🥂✨
What happens when a real human shows up for a clinical trial patient? 👇
James was dropping off. Missed diaries. Unsynced wearable. Week 3 of a vaccine study.
Our concierge called him. Stayed on the phone. Got everything sorted.
✅ Diary completion: 18% → 91%
✅ Wearable adherence: 24% → 88%
✅ Retention: 96%
✅ Dropouts after that call: zero
This is Video 3 of our series showing why human engagement isn’t a nice-to-have in clinical trials — it’s the whole game.
📌 Book a demo — link in bio.
—
Had a great conversation with Denali Rose on the podcast about where clinical research is really headed — and what still has not changed enough.
A few themes stood out:
Clinical research still struggles with the same core challenges we were talking about years ago.
Poor communication.
Disconnected stakeholders.
Operational friction at the site level.
And too many solutions built in isolation instead of with the people who actually use them.
We also talked about:
why site sustainability matters more than ever
where AI may help in clinical trials — and where it is still overhyped
why interoperability still matters
why patient engagement and education remain deeply under-addressed
and why authenticity and transparency are still some of the most important things this industry can offer
One thing I appreciated most from this conversation was Denali’s perspective on sites: they do critical work, care deeply, and deserve better support, better autonomy, and better financial viability.
That is a conversation this industry needs to keep having.
If you work in clinical operations, site strategy, patient engagement, clinical trial technology, or digital health, this one is worth the listen.
🎙️ Watch / listen here: https://lnkd.in/gbumN-yR
What do you think is the biggest issue we still have not solved in clinical research?
Spotify: https://lnkd.in/gcREmuY5
Click here to claim your Sponsored Listing.
Category
Website
Address
8100 Wayzata Boulevard
Golden Valley, MN
55426